Back

OncoDots

Info

Clinical trials for lymphoma in Romania

Which trials are taking patients now, in which cities, and what to ask your doctor. The official record stays with the national agency.

← All cancer types

How to read this list

Each row is an authorised trial looking for participants. The plain-language title is written by our editorial team, and underneath it you can see the original registry title — so you can check for yourself that we did not change the meaning. We cannot tell you whether you are eligible, and we do not publish the hospital name: the international registry does not carry it, and a wrong name would send you to a room where nobody expects you. For the centre and the team's contact details, open the official record.

Trials recruiting now

0 of 9 titles have been rewritten in plain language by our editorial team. The rest still show the registry's protocol wording.

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

A treatment is being testedPhase 2

Running in: Fundeni Clinical Institute, București · Institutul Oncologic Cluj, Cluj-Napoca · Spitalul Clinic Municipal Filantropia Craiova, Craiova · Institutul Regional de Oncologie, Iași · Ovidius Clinical Hospital OCH, Ovidiu

See the official record ↗ NCT06588478

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

A treatment is being testedPhase 2

Running in: Centrul de Diagnostic si Tratament Oncologic Brasov ( Site 1802), Brașov · Spitalul Clinic Colțea ( Site 1805), București · Institutul Regional de Oncologie Iasi ( Site 1801), Iași · Ovidius Clinical Hospital ( Site 1804), Ovidiu

See the official record ↗ NCT04728893

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

A treatment is being testedPhase 3

Running in: Centrul de Diagnostic si Tratament Oncologic Brasov ( Site 2402), Brașov · Spitalul Clinic Colțea ( Site 2401), București · Institutul Oncologic Cluj ( Site 2404), Cluj-Napoca · Spital Judetean Sibiu ( Site 2405), Sibiu

See the official record ↗ NCT06717347

Global Trial in APG2575 for Patients With CLL/SLL

A treatment is being testedPhase 3

Running in: Ascentage Investigative Site, București · Ascentage Investigative Site, Cluj-Napoca · Ascentage Investigative Site, Timișoara

See the official record ↗ NCT06104566

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

A treatment is being testedPhase 3

Running in: Fundeni Clinical Institute /ID# 260296, București · Institutul Oncologic Prof Dr. Ion Chiricuta Cluj Napoca /ID# 259704, Cluj-Napoca · Institutul Regional de Oncologie /ID# 259697, Iași

See the official record ↗ NCT06191744

A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

A treatment is being testedPhase 3

Running in: Coltea Clinical Hospital, București · Institutul Oncologic Prof Dr Ion Chiricuta Cluj Napoca, ClujNapoca · Institutul Regional de Oncologie Iasi, Iași

See the official record ↗ NCT06973187

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

A treatment is being testedPhase 2

Running in: Bucharest Oncology Institute "Prof.Dr.Al. Trestioreanu", București · The Oncology Institute "Prof. Dr. Ion Chiricuţă" I.O.C.H., Cluj-Napoca

See the official record ↗ NCT04920617

Study of SGR-1505 in Mature B-Cell Neoplasms

A treatment is being testedPhase 1

Running in: ARENSIA Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, București · ARENSIA Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj Napoca, Cluj-Napoca

See the official record ↗ NCT05544019

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

Observational study — you do not receive a new treatment

Running in: Cluj Napoca_Ion Chiricuta Oncology Institute, Cluj-Napoca

See the official record ↗ NCT03964480

Source: ClinicalTrials.gov, the public registry of the US National Library of Medicine. Read automatically, last on 31 Jul 2026.

Worth reading before you talk to your doctor

Material from our library to help you prepare your questions.

Where the official information lives

The road ends at the registry, not with us. That is where each trial's full record is — including the things we do not publish.

Where the data on this page comes from

The counts are read automatically from ClinicalTrials.gov and show trials marked there as recruiting, with at least one site in Romania. We do not verify each one by hand, and we cannot guarantee that a trial marked “recruiting” is still taking patients today — the registry lags behind what happens in the hospital. For any decision, the official record and your doctor have the final word.

Language
Country
RORomania

Show information for:

OncoDots shows information, services and emergency numbers for the selected country. Language and country are separate — choose each independently.

Report a problem